Adtalem Global Education Inc

Adtalem Global Education Inc(ATGE)股票分析

$98.540

+1.941 (+1.97%)收盤時

Loading chart…
最高
99.720
開盤
96.000
成交量加權均價
98.05
成交量
683.15K
市值
2.48B
最低
95.900
成交金額
66.99M
企業價值/稅息折舊攤銷前利潤(TTM)
9.75

Adtalem Global Education Inc. is a provider of healthcare education in the United States, preparing a diverse workforce with academic programs. Its healthcare programs include nursing, medicine, veterinary medicine, social and behavioral sciences and more. Its segments include Chamberlain, Walden, and Medical and Veterinary. Chamberlain segment offers degree and certificate programs in the nursing and health professions postsecondary education industry. Walden segment offers degree and certificate programs, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. Medical and Veterinary segment offers degree and certificate programs in the medical and veterinary postsecondary education industry. This segment includes American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.

AI 分析 of Adtalem Global Education Inc (ATGE)

持有

Adtalem Global Education Inc (ATGE) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows solid financial performance and positive analyst sentiment, the technical indicators suggest a bearish trend, and there are no strong trading signals or immediate positive catalysts to justify an entry point right now.

分析師評級(5)

上檔空間 +63.39%
持有
2 買進
3 持有
0 賣出
目前: 98.54
最低
138.00
平均
161.00
最高
175.00

BMO Capital

2026-01-30

目標價

$138

優於大盤

Barrington

2025-10-15

目標價

$170

優於大盤

Barrington

2025-08-08

目標價

$150

優於大盤

Baird

2025-08-08

目標價

$169

優於大盤

BMO Capital

2025-05-12

目標價

$132

優於大盤

估值指標

Adtalem Global Education Inc(ATGE)目前預期本益比為 15.98,5 年平均預期本益比為 11.35。

預期本益比

高估
5 年均值 P/E
11.35
目前P/E
15.98
高估
14.55
低估
8.14

預期 EV/EBITDA

高估
5 年均值 EV/EBITDA
7.82
目前EV/EBITDA
9.75
高估
9.39
低估
6.24

預期股價營收比

高估
5 年均值 P/S
1.49
目前P/S
2.27
高估
1.99
低估
1.00

Alphio AI 對 ATGE 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%ATGE

$150.34

情境價格

基

基準

基準 · 50%ATGE

$141.08

情境價格

悲

悲觀

悲觀 · 25%ATGE

$125.27

情境價格

持有 ATGE 的大戶

Ö

ÖKoworld Lux S.A.

+ 持有ATGE

+2.04%

3個月報酬率

A

Ariel Investments, LLC

+ 持有ATGE

-5.64%

3個月報酬率

事件時間軸

2026-01-28 (ET)

16:30:00

Adtalem Maintains FY 2026 Revenue Guidance at $1.9B-$1.94B

16:20:00

Adtalem Global Education Q2 Revenue $503.385M Beats Expectations

2025-12-15 (ET)

10:10:00

Adtalem Global Education Stock Rises 6.5% to $98.92

08:10:00

Adtalem Completes $150M Share Repurchase and Secures $750M New Buyback Authorization

2025-11-05 (ET)

07:25:26

Adtalem confirms FY26 adjusted EPS forecast of $7.60-$7.90, aligning with consensus of $7.81

資訊

ATGE 常見問題 —— 由 Alphio AI 解答

Adtalem Global Education Inc. is a provider of healthcare education in the United States, preparing a diverse workforce with academic programs. Its healthcare programs include nursing, medicine, veterinary medicine, social and behavioral sciences and more. Its segments include Chamberlain, Walden, and Medical and Veterinary. Chamberlain segment offers degree and certificate programs in the nursing and health professions postsecondary education industry. Walden segment offers degree and certificate programs, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. Medical and Veterinary segment offers degree and certificate programs in the medical and veterinary postsecondary education industry. This segment includes American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It operates in the Academic & Educational Services sector (SERVICES-EDUCATIONAL SERVICES industry).

Adtalem Global Education Inc (ATGE) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows solid financial performance and positive analyst sentiment, the technical indicators suggest a bearish trend, and there are no strong trading signals or immediate positive catalysts to justify an entry point right now.

5 analysts cover ATGE: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 161.00.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易